CAS: 29122-68-7; Atenolol

该化合物是一种选择性的乙-1肾上腺对抗物,主要用于治疗高血压和某些心脏病,如心血管和心律不齐;一种在水中溶解并具有中分子重量的白对白结晶粉粉,阿提诺洛的化学配方是C14H22N2O3, 其特点是一种氢氧基,一种醚联系和一个矿物质组,有助于其药理活动;阿提诺洛通过阻截乙-1受体进入心脏,导致心率和耐受性下降,最终降低血压和心血管氧需求;它一般是口服,具有相对长的半衰期,允许一次服.阿提诺洛的化学配方一般都很好,但潜在的副作用可能包括疲劳,眩晕和胸腺炎.与任何药物一样,病人必须咨询保健专业人员,以便适当使用和监测.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号29122-69-8 4-(环氧乙基甲氧基)苯乙酰胺 | CAS号75-31-0 异丙胺 | CAS号29277-73-4 2-[4-[2-hydroxy... | CAS号623-05-2 对羟基苯甲醇 | CAS号14191-95-8 对羟基苯乙腈 | CAS号17194-82-0 对羟基苯乙酰胺 | CAS号35198-42-6 4-(2-Oxiranylme... | CAS号56715-13-0 (R)-(+)-阿替洛尔 | CAS号93379-54-5 (S)-(-)-阿替洛尔 | CAS号4747-21-1 N-甲基异丙胺 | CAS号52299-08-8 2-[4-(carboxyme...

合成工艺路线路线简述

  • 合成目标产物 Atenolol 主要起始原料 2-[4-(2,3-Epoxypropoxy)Phenyl]Acetamide And Isopropylamine
  • (文献来源)合成步骤主要原料 2-[4-(2,3-Epoxypropoxy)Phenyl]Acetamide 和 Isopropylamine
4-羟基苯乙酰胺置于potassium Carbonate体系中,用 N,N-二甲基甲酰胺,丙酮 用作溶剂,化学反应 48.0H,反应生成阿替洛尔
参考文献:伯胺在溶剂指导下的环氧开环反应,用于合成β-氨基醇
标题:伯胺在溶剂指导下的环氧开环反应,用于合成β-氨基醇
摘要:摘要 据报道,在没有任何催化剂的情况下,可以由多种环氧化物和伯直链伯胺高效合成β-氨基醇,从而具有高收率和区域选择性.多种极性混合溶剂体系允许仲氨基醇相对于叔氨基醇的选择性形成.反应范围扩展到各种带有复杂官能团的芳族和脂族取代的环氧化物和伯胺. 据报道,在没有任何催化剂的情况下,可以由多种环氧化物和伯直链伯胺高效合成β-氨基醇,从而具有高收率和区域选择性.多种极性混合溶剂体系允许仲氨基醇相对于叔氨基醇的选择性形成.反应范围扩展到各种带有复杂官能团的芳族和脂族取代的环氧化物和伯胺.
Doi:10.1055/s-0036-1588356

海关参考信息

专利信息


专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:WO-2011024039-A1
优先权日:2009-08-25
标题 :Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
发明人:POTLURI RAMESH BABU; KODALI HARI PRASAD; VENTURI SRINIVASA RAO; TADIMALLA VENKATA SRIHARI
权利人:POTLURI RAMESH BABU; KODALI HARI PRASAD; VENTURI SRINIVASA RAO; TADIMALLA VENKATA SRIHARI
摘要:An objective of the present invention is to develop commercially viable methods for the synthesis of 5-[2-phenylsulfony)ethyl]-1H-indole of Formule (II), where R 1 and R 2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (II). Another objective of the present invention is to convert the product Formula (II) to Formula (I) in high yields, where R 1 and R 2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (I). One of the first processes attempted was by reacting the indole derivative of Formula (III) with aryl vinyl sulphones of Formula (V) as shown in Scheme-III. Another process attempted was by reacting the aniline derivative of Formula (VI) with aryl sulphones of Formula (VII) as shown in Scheme-III. Scheme IV.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-10973847-B2
优先权日:2017-06-30
标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

专利号:US-10005720-B2
优先权日:2013-04-05
标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

专利号:US-2003050305-A1
优先权日:2000-05-22
标题:Thromboxane inhibitors, compositions and methods of use
发明人:TEJADA INIGO SAENZ DE
摘要:The present invention describes methods for treating or preventing sexual dysfunctions in males and females, and for enhancing sexual responses in males and females by administering a therapeutically effective amount of at least one thromboxane inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and/or at least one vasoactive agent. The male or female may preferably be diabetic. The present invention also provides novel compositions comprising at least one thromboxane inhibitor, and, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase, and, optionally, at least one therapeutic agent, such as, vasoactive agents, nonsteroidal antiinflanmmatory compounds (NSAIDs), selective cyclooxygenase-2 (COX-2) inhibitors, anticoagulants, angiotensin converting enzymes (ACE) inhibitors, angiotensin II receptor antagonists, renin inhibitors, and mixtures thereof. The present invention also provides methods for treating or preventing ischemic heart disorders, myocardial infarction, angina pectoris, stroke, migraine, cerebral hemorrhage, cardiac fatalities, transient ischaemic attacks, complications following organ transplants, coronary artery bypasses, angioplasty, endarterectomy, atherosclerosis, pulmonary embolism, bronchial asthma, bronchitis, pneumonia, circulatory shock of various organs, nephritis, graft rejection, cancerous metastases, pregnancy-induced hypertension, preeclampsia, eclampsia, thrombotic and thromboembolic disorders, intrauterine growth, gastrointestinal disorders, renal diseases and disorders, disorders resulting from elevated uric acid levels and dysmenorrhea, and for inhibiting platelet aggregation or platelet adhesion or relaxing smooth muscles.
北京梅尔森医药技术开发有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bjmerson.com
电话: 086-10-80484574,80483447👤
📞北京梅尔森医药技术开发有限公司 ⚠️参考联系方式

销售电话:086-10-80484574,80483447
邮箱:sales@bjmerson.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
赤峰艾克制药科技股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.arker.com.cn
电话: 0476-8220200👤
📞赤峰艾克制药科技股份有限公司 ⚠️参考联系方式

销售电话:0476-8220200
邮箱:kykfb@arker.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
广州佰瑞医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.gzbr.com.cn
电话: 020-37653626 13682223272👤
📞广州佰瑞医药有限公司 ⚠️参考联系方式

销售电话:020-37653626 13682223272
邮箱:goldg@gzbr.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
郑州佰宇药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zzbaiyu.com
企业联系电话:13938569199👤
📞郑州佰宇药业有限公司 ⚠️参考联系方式
联系人:陈经理
电话:13938569199


邮箱:13938569199@163.com
通信地址: 河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
邮编: 450000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Gong Y, McDonough CW, Beitelshees AL, Rouby NE, Hiltunen TP, O'Connell JR, Padmanabhan S, Langaee TY, Hall K, Schmidt SO, Curry RW Jr, Gums JG, Donner KM, Kontula KK, Bailey KR, Boerwinkle E, Takahashi A, Tanaka T, Kubo M, Chapman AB, Turner ST, Pepine CJ, Cooper-DeHoff RM, Johnson JA. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension. J Hypertens. 2015 Nov;33(11):2278-85. doi: 10.1097/HJH.0000000000000714.
5: Svan A, Hedeland M, Arvidsson T, Jasper JT, Sedlak DL, Pettersson CE. Rapid chiral separation of atenolol, metoprolol, propranolol and the zwitterionic metoprolol acid using supercritical fluid chromatography-tandem mass spectrometry - Application to wetland microcosms. J Chromatogr A. 2015 Aug 28;1409:251-8. doi: 10.1016/j.chroma.2015.07.075. Epub 2015 Jul 21. doi: 10.1016/j.jvc.2015.04.001. Epub 2015 Jul 26. doi: 10.1038/nrcardio.2015.95. Epub 2015 Jun 16. doi: 10.3349/ymj.2015.56.4.1114.
10: Meurs KM, Stern JA, Reina-Doreste Y, Maran BA, Chdid L, Lahmers S, Keene BW, Mealey KL. Impact of the canine double-deletion β1 adrenoreceptor polymorphisms on protein structure and heart rate response to atenolol, a β1-selective β-blocker. Pharmacogenet Genomics. 2015 Sep;25(9):427-31. doi: 10.1097/FPC.0000000000000152. doi: 10.1016/j.bbamem.2015.04.016. Epub 2015 May 8. doi: 10.1016/j.saa.2015.04.077. Epub 2015 Apr 30. doi: 10.1371/journal.pone.0122726. eCollection 2015.

合成参考文献


参考文献:10.1016/j.autneu.2010.01.007
摘要:Wakasugi R, Nakamoto T, Matsukawa K. The effects of adrenalectomy and autonomic blockades on the exercise tachycardia in conscious rats. Auton Neurosci. 2010 Jun 24;155(1-2):59–67. doi: 10.1016/j.autneu.2010.01.007.
参考文献:10.1007/s00246-010-9670-4
摘要:Spar DS, Silver ES, Hordof AJ, Torres A, Liberman L. Coronary artery spasm during radiofrequency ablation of a left lateral accessory pathway. Pediatr Cardiol. 2010 Jul;31(5):724–7. doi: 10.1007/s00246-010-9670-4.
参考文献:10.1021/ac902854g
摘要:Liu J, Wang H, Manicke NE, Lin JM, Cooks RG, Ouyang Z. Development, characterization, and application of paper spray ionization. Anal Chem. 2010 Mar 15;82(6):2463–71. doi: 10.1021/ac902854g.
参考文献:10.4061/2011/417594
摘要:Demede M, Pandey A, Innasimuthu L, Jean-Louis G, McFarlane SI, Ogedegbe G. Management of Hypertension in High-Risk Ethnic Minority with Heart Failure. International Journal of Hypertension. 2011;2011():1–8. doi: 10.4061/2011/417594.
参考文献:10.1007/s10895-011-0911-6
摘要:Jouyban A, Shaghaghi M, Zoghi E, Karami N, Clark BJ, Acree WE. Mathematical representation of fluorescence intensity of probes in aqueous binary solvent mixtures. J Fluoresc. 2011 Nov;21(6):2111–6. doi: 10.1007/s10895-011-0911-6.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知